Zhitong Finance App News, Touyun Biotech (01332) announced that on August 25, 2026, the company plans to allocate and issue 123 million new shares to the subscriberer, Mr. Peng Yi, which is equivalent to about 4.38% of the company's issued share capital on the date of this announcement and about 4.20% of the company's issued share capital expanded through allotment and issuance of subscription shares. The subscription price was HK$0.122 per share, a discount of approximately 18.67% from the closing price of HK$0.150 per share on August 25. The total proceeds and net proceeds from the subscription were HK$15.06 million and HK$14.99 million respectively. The Group intends to use the net proceeds as the Group's general working capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.